NATA accredits the primary antidoping lab for the 2022 FIFA World Cup

Industry News November 11, 2022
NATA accredits the primary antidoping lab for the 2022 FIFA World Cup
NATA team

NATA is actively involved in the world’s largest sporting event – accrediting the primary laboratory conducting player drug testing. 

The ‘Anti Doping Lab Qatar’ (ADLQ) in Doha, Qatar, who NATA accredited in 2018, has been conducting the drug testing for the FIFA World Cup in Qatar. 

The ADLQ is compliant with ISO/IEC 17025 and is accredited for testing of ‘Athletes Biological Passport’ (ABP). 

FIFA and the anti-doping process 

The anti-doping process is used to safeguard the physical health and mental integrity of players, as well as upholding the ethics of sport and ensure that all competitors have an equal chance. 

To do this, FIFA works with the World Anti-Doping Agency (WADA) and national anti-doping organisations. 

FIFA sets the anti-doping rules in line with the WADA Code and has a worldwide network of professional and trained doping control officers, laboratories and accreditation bodies who help manage doping controls in and out of competition. 

FIFA’s Anti-Doping Regulations establish the doping control process and the sanctions that apply if a player is found to have broken the rules. 

NATA is proud be part of this process and wish ADLQ every success for the 2022 Word Cup. 

You can learn more about ADLQ here – ADLQ – Anti Doping Lab Qatar (adlqatar.qa) or the NATA accreditation process – www.nata.com.au